Ways of Regulating Drugs in the 19th and 20th Centuries

1. General Introduction
Jean-Paul Gaudillière, Volker Hess

2. Secrets, Bureaucracy, and the Public: Drug Regulation in Early 19th-Century Prussia
Volker Hess

3. Making Salvarsan: Experimental Therapy and the Development and Marketing of Salvarsan at the Crossroads of Science, Clinical Medicine, Industry, and Public Health
Axel C. Hüntelmann

4. Professional and Industrial Drug Regulation in France and Germany: The Trajectories of Plant Extracts
Jean-Paul Gaudillière

5. Making Risks Visible: The Science, Politics, and Regulation of Adverse Drug Reactions
Harry M. Marks

6. Regulating Drugs, Regulating Diseases: Consumerism and the US Tolbutamide Controversy
Jeremy A. Greene

7. Thalidomide, Drug Safety Regulation, and the British Pharmaceutical Industry: The Case of Imperial Chemical Industries
Viviane Quirke

8. What’s in a Pill? On the Informational Enrichment of Anti-Cancer Drugs
Alberto Cambrosio, Peter Keating, Andrei Mogoutov

9. Treating Health Risks or Putting Healthy Women at Risk: Controversies around Chemoprevention of Breast Cancer
Ilana Löwy

10. AZT and Drug Regulatory Reform in the Late 20th-Century US
Donna A. Messner

11. Professional, Industrial, and Juridical Regulation of Drugs: The 1953 Stalinon Case and Pharmaceutical Reform in Postwar France
Christian Bonah

12. Managing Double Binds in the Pharmaceutical Prescription Market: The Case of Halcion
Toine Pieters, Stephen Snelders

13. Pharmaceutical Patent Law In-the-Making: Opposition and Legal Action by States, Citizens, and Generics Laboratories in Brazil and India
Maurice Cassier

Avainsanat: History, Modern History, Pharmacology/Toxicology, Pharmacy, History of Science, European History, History of Medicine